Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 20% cut in fees, from May 2009

Is there any formal company statement that indicates that PTSC was seriously considering divesting itself of PDGS, or that PTSC will not be part of any PDGS service/product offering ?

From the 10Q:

Accordingly, we are in the process of examining alternatives that could allow for the partnering or divestiture of PDSG. If successful, these measures may provide for a further reduction in expenses and cash use, or additionally in the event of divestiture, cash proceeds.

FWIW,

SGE

Share
New Message
Please login to post a reply